Question 1

What are the potential benefits of lurasidone compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy) clinical trial (NCT00868699). Contact the study team or your healthcare provider for specific answers.

Question 2

How long will I need to participate in the trial, and what does that involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy) clinical trial (NCT00868699). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while taking lurasidone?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy) clinical trial (NCT00868699). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy) clinical trial (NCT00868699). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy) clinical trial (NCT00868699). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy) clinical trial (NCT00868699). Contact the study team or your healthcare provider for specific answers.

What this study is about